Esperion Stock Downgraded Amid Merck’s Competitive Pressure
Esperion's stock downgraded by BofA due to rising competition from Merck's PCSK9 inhibitors. Analysts weigh in on efficacy and market ...
- Latest
- Trending
Esperion's stock downgraded by BofA due to rising competition from Merck's PCSK9 inhibitors. Analysts weigh in on efficacy and market ...
Ethereum at a crucial point as it enters a consolidation phase; traders eye potential volatility. Will ETH break out or ...
BofA raises ASM International NV's price target to €860, citing underestimated growth and strong revenue prospects as a "critical AI ...
Analysts see Bitcoin, Ethereum, XRP, Dogecoin, Toncoin, and Cardano undervalued per MVRV metric; market up 0.6%, possible short-term price bounce.
Morgan Stanley upgrades ASM International to Overweight, raises target to €800, citing strong AI-driven growth and increased order momentum.
Arthur Hayes buys Dogecoin (DOGE) amid market decline, betting on recovery despite oversold conditions and critical support breaches.
"Ethereum price rises amid SEC decision to halt investigation. Could this propel ETH to $4K? Analysis suggests cautious optimism. Read ...
"Revealed: Expert Predicts Next Bitcoin Cycle Top | Discover when Bitcoin may peak again, potential gains, and investment opportunities."
Crypto analyst Vapor predicts meme coins like Dogecoin and Shiba Inu will lead the altcoin season, offering high potential gains ...
Macquarie analysts remain optimistic about AppLovin despite Apple's new AdAttributionKit, maintaining an "Outperform" rating and $115 price target.
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.